Selective cyclooxygenase 2 inhibitor induces indefinite survival of fully allogeneic cardiac grafts and generates CD4+ regulatory cells

Journal of Thoracic and Cardiovascular Surgery

Volumn 130, Issue 4, 2005, Pages 1167-1174

  Yokoyama, Takeshi ^b   Aramaki, Osamu ^b   Takayama, Tadatoshi ^b   Takano, Seigo ^b   Zhang, Qi ^b   Shimazu, Motohide ^b   Kitajima, Masaki ^b   Ikeda, Yoshifumi ^b   Shirasugi, Nozomu ^a   Niimi, Masanori ^b  

^a TEIKYO UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CD4 ANTIGEN; CYCLOOXYGENASE 2 INHIBITOR; INTERLEUKIN 10; INTERLEUKIN 4; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIAC GRAFT REJECTION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; ENZYME INHIBITION; GRAFT SURVIVAL; HEART GRAFT; HEART TRANSPLANTATION; IMMUNE RESPONSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECIPIENT; SPLEEN CELL; T LYMPHOCYTE;

ANIMALS; CYCLOOXYGENASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; GRAFT SURVIVAL; HEART TRANSPLANTATION; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; NITROBENZENES; SULFONAMIDES; T-LYMPHOCYTES, REGULATORY; TIME FACTORS;

EID: 26444529794     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2005.06.031     Document Type: Article

References (26)

1. M.D. Denton, C.C. Magee, M.H. Sayegh Immunosuppressive strategies in transplantation Lancet 353 1999 1083 1091
2. J.R. Vane, Y.S. Bakhle, R.M. Botting Cyclooxygenases 1 and 2 Annu Rev Pharmacol Toxicol 38 1998 97 120
3. C.J. Hawkey COX-2 inhibitors Lancet 353 1999 307 314
4. T. Kawamori, C.V. Rao, K. Seibert, B.S. Reddy Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis Cancer Res 58 1998 409 412
5. W. Smalley, W.A. Ray, J. Daugherty, M.R. Griffin Use of nonsteroidal anti-inflammatory drugs and incidence of colorectal cancer a population-based study Arch Intern Med 159 1999 161 166
6. P.L. McGeer, M. Schulzer, E.G. McGeer Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease a review of 17 epidemiologic studies Neurology 47 1996 425 432
7. C.D. Stone, B.R. Rosengard, S.M. Boorstein, R.C. Robbins, H.A. Hennein, R.E. Clark Prostaglandin E2 inhibits in vitro and in vivo lymphocyte responses in allogeneic transplantation Ann Thorac Surg 49 1990 927 931
8. J.F. Shaw Prolongation of rat cardiac allograft survival by treatment with prostacyclin or aspirin during acute rejection Transplantation 35 1983 526 529
9. X. Yang, N. Ma, M.J. Szabolcs, J. Zhong, E. Athan, R.R. Sciacca Upregulation of COX-2 during cardiac allograft rejection Circulation 101 2000 430 438
10. B. Hausknecht, S. Voelkl, R. Riess, S. Gauer, M. Goppelt-Struebe Expression of cyclooxygenase-2 in biopsies obtained from human transplanted kidneys undergoing rejection Transplantation 76 2003 109 114
11. N. Futaki, I. Arai, Y. Hamasaka, S. Takahashi, S. Higuchi, S. Otomo Selective inhibition of NS-398 on prostanoid production in inflamed tissue in rat carrageenan-air-pouch inflammation J Pharm Pharmacol 45 1993 753 755
12. N. Futaki, S. Takahashi, M. Yokoyama, I. Arai, S. Higuchi, S. Otomo NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro Prostaglandins 47 1994 55 59
13. M. Niimi The technique for heterotopic cardiac transplantation in mice experience of 3000 operations by one surgeon J Heart Lung Transplant 20 2001 1123 1128
14. M.E. Billingham, N.R. Cary, M.E. Hammond, J. Kemnitz, C. Marboe, H.A. McCallister A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation J Heart Transplant 9 1990 587 593
15. W.W. Hancock, R. Buelow, M.H. Sayegh, L.A. Turka Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes Nat Med 4 1998 1392 1396
16. Y. Akiyama, N. Shirasugi, N. Uchida, K. Matsumoto, M. Kitajima, H. Bashuda B7/CTLA4 pathway is essential for generating regulatory cells after intratracheal delivery of alloantigen in mice Transplantation 74 2002 732 738
17. P. Perros, D.R. Weightman Measurement of cell proliferation by enzyme-linked immunosorbent assay (ELISA) using a monoclonal antibody to bromodeoxyuridine Cell Prolif 24 1991 517 523
18. N. Ma, M.J. Szabolcs, J. Sun, A. Albala, R.R. Sciacca, M. Zhong The effect of selective inhibition of cyclooxygenase (COX)-2 on acute cardiac allograft rejection Transplantation 74 2002 1528 1534
19. K.J. Wood, N.D. Jones, A.R. Bushell, P.J. Morris Alloantigen-induced specific immunological unresponsiveness Philos Trans R Soc Lond B Biol Sci 356 2001 665 680
20. H. Hackstein, A.E. Morelli, A.T. Larregina, R.W. Ganster, G.D. Papworth, A.J. Logar Aspirin inhibits in vitro maturation and in vivo immunostimulatory function of murine myeloid dendritic cells J Immunol 166 2001 7053 7062
21. D.S. Whittaker, K.S. Bahjat, L.L. Moldawer, M.J. Clare-Salzler Autoregulation of human monocyte-derived dendritic cell maturation and IL-12 production by cyclooxygenase-2-mediated prostanoid production J Immunol 165 2000 4298 4304
22. D. Bell, J.W. Young, J. Banchereau Dendritic cells Adv Immunol 72 1999 255 324
23. H. Groux, A. O'Garra, M. Bigler, M. Rouleau, S. Antonenko, J.E. de Vries A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis Nature 389 1997 737 742
24. A.M. Faria, H.L. Weiner Oral tolerance mechanisms and therapeutic applications Adv Immunol 73 1999 153 264
25. A. Bushell, M. Niimi, P.J. Morris, K.J. Wood Evidence for immune regulation in the induction of transplantation tolerance a conditional but limited role for IL-4 J Immunol 162 1999 1359 1366
26. M. Hara, C.I. Kingsley, M. Niimi, S. Read, S.E. Turvey, A.R. Bushell IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo J Immunol 166 2001 3789 3796